Viewing Study NCT05173168


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2025-12-29 @ 9:14 AM
Study NCT ID: NCT05173168
Status: COMPLETED
Last Update Posted: 2022-04-29
First Post: 2021-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pilot Study to Assess the Safety Profile of resB®
Sponsor: ResBiotic Nutrition, Inc.
Organization:

Study Overview

Official Title: A Pilot Study to Assess the Safety Profile of resB®
Status: COMPLETED
Status Verified Date: 2022-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study investigates the safety and tolerability of 4-week, twice daily supplementation of resB® Lung Support in asthma patients and healthy participants.
Detailed Description: resB® Lung Support is a probiotic dietary supplement that contains 3 probiotic strains and 3 herbal extracts: turmeric, holy basil, and vasaka. The proprietary herbal and probiotic blend is formulated to support proper lung structure and function. The study investigates the safety and tolerability of twice-daily supplementation of resB® Lung Support in asthma patients and healthy participants for 4 weeks.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: